Drug Shortage Report for THALLIUM

Last updated on 2019-05-11 History
Report ID 81781
Drug Identification Number Not Applicable/non applicable
Brand name THALLIUM
Common or Proper name Tl-201 Injection
Company Name LANTHEUS MI CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) THALLIUM CHLORIDE
Strength(s) 2MCI
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10mL glass vial
ATC code V09GX
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-03-15
Estimated end date
Actual end date 2019-05-10
Shortage status Resolved
Updated date 2019-05-11
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1111 DR. FREDERIK-PHILIPS BLVD., SUITE 600
MONTREAL, QUEBEC
CANADA H4M 2X6
Company contact information lmicanada@lantheus.com 1-800-811-5500

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-04-16 English Compare
v2 2019-04-16 English Compare
v3 2019-04-16 English Compare
v4 2019-04-16 French Compare
v5 2019-05-10 English Compare
v6 2019-05-10 French Compare
v7 2019-05-11 English Compare

Showing 1 to 7 of 7